Skip to main content

Advertisement

SpringerLink
Log in

Suspected Liver Injury and the Dilemma of Causality

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

For causality assessment in cases of suspected liver injury, RUCAM provides objective and transparent results and should be the preferred tool rather than the DILIN method, which is based on subjective opinion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Heidemann LA, Navarro VJ, Ahmad J, et al. Severe acute hepatocellular injury attributed to OxyELITE Pro: A case series. Dig Dis Sci. 2016;61:2741–2748. doi:10.1007/s10620-016-4181-7.

    Article  CAS  PubMed  Google Scholar 

  2. Teschke R, Schulze J, Eickhoff A, Wolff A, Frenzel C. Review article: mysterious Hawaii liver disease case—naproxen overdose as cause rather than OxyELITE Pro? J Liver Clin Res. 2015;2. http://www.jscimedcentral.com/Liver/liver-2-1013.pdf.

  3. Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: a pragmatic and clinical approach to solve the problem. Ann Hepatol. 2016;15:91–119.

    Article  PubMed  Google Scholar 

  4. Teschke R, Eickhoff A. The Honolulu liver disease cluster at the Medical Center: its mysteries and challenges. Int J Mol Sci. 2016;17:476. doi:10.3390/ijms17040476.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2016;17:14. doi:10.3390/ijms17010014.

    Article  Google Scholar 

  6. Hayashi PH. Drug-induced liver injury network causality assessment: criteria and experience in the United States. Int J Mol Sci. 2016;17:201. doi:10.3390/ijms17020201.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Sarges P, Steinberg JM, Lewis JH. Drug-induced liver injury: highlights from a review of the 2015 literature. Drug Saf. 2016;39:561–575. doi:10.1007/s4026401604278.

    Article  Google Scholar 

  8. Frenzel C, Teschke R. Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci. 2016;17:588. doi:10.3390/ijms17050588.

    Article  PubMed Central  Google Scholar 

  9. Klontz KC, DeBeck HJ, LeBlanc P, et al. The role of adverse event reporting in the FDA response to a multistate outbreak of liver disease associated with a dietary supplement. Pub Health Rep. 2015;130:526–532.

    Article  Google Scholar 

  10. Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug induced liver injury network prospective study: rationale, design, and conduct. Drug Saf. 2009;32:55–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the RUCAM. Hepatology. 2010;51:2117–2126.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lucena MI, Andrade RJ, Kaplowitz N, et al. Phenotypic characterization of Idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009;49:2001–2009.

    Article  PubMed  Google Scholar 

  13. Navarro V, Khan I, Bjornsson E, et al. Liver injury from herbal and dietary supplements hepatology. Hepatology. 2016. doi:10.1002/hep.28813/epdf.

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, Leimenstrasse 20, 63450, Hanau, Germany

    Rolf Teschke & Axel Eickhoff

Authors
  1. Rolf Teschke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Axel Eickhoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rolf Teschke.

Ethics declarations

Conflict of interest

Rolf Teschke received an honorarium by Merz Pharmaceuticals and Max Zeller Pharmaceuticals for lectures at scientific meetings, and by Covington & Burling LLP Washington DC and Weber & Weber Inc. for consultation. Axel Eickhoff received no honoraria or has a conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teschke, R., Eickhoff, A. Suspected Liver Injury and the Dilemma of Causality. Dig Dis Sci 62, 1095–1098 (2017). https://doi.org/10.1007/s10620-016-4442-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4442-5

Keywords

Search

Navigation